The use of granulocyte colony stimulating factor to promote wound healing in a neutropenic patient after head and neck surgery.

Abstract

BACKGROUND:

Neutropenia and neutrophil dysfunction, in association with a variety of diseases, has been shown to play a role in poor wound healing. Wound breakdown with fistula formation in patients undergoing total laryngectomy results in significant morbidity and increased hospital stay. Although malnutrition, prior radiation, diabetes, and other diseases are recognized as factors predisposing patients with head and neck cancer to developing fistulas, neutrophil dysfunction should also be considered. Granulocyte colony stimulating factor (G-CSF) has been used successfully to treat neutropenia and neutrophil dysfunction.

METHODS:

This study was conducted as a case report.

RESULTS:

We present the first report of a neutropenic head and neck cancer patient with a persistent wound of 6 months' duration who showed dramatic improvement after treatment with G-CSF.

CONCLUSION:

We conclude that G-CSF may represent a useful adjunct in patients with persistent wound healing problems and neutropenia despite adequate treatment by conventional means. Further clinical experience with G-CSF in patients with delayed healing is indicated.

• Authors: D T Cody 2nd, G F Funk, D Wagner, P W Gidley, S M Graham, H T Hoffman
• Journal: Head & neck (Head Neck) Vol. 21 Issue 2 Pg. 172-5 (Mar 1999) ISSN: 1043-3074 [Print] United States
• PMID: 10091988 (Publication Type: Case Reports, Journal Article)

Chemical References

• Granulocyte Colony-Stimulating Factor

Topics

• Cutaneous Fistula (etiology, therapy)
• Female
• Fistula (therapy)
• Granulocyte Colony-Stimulating Factor (therapeutic use)
• Humans
• Laryngectomy (adverse effects)
• Middle Aged
• Neutropenia (etiology, physiopathology)
• Pharyngeal Diseases (etiology, therapy)
• Wound Healing